Title Common variant rs 356182 near SNCA defines a Parkinson ' s disease endophenotype

[1]  Ekaterina Nosova,et al.  α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease , 2016, Annals of neurology.

[2]  H. Shang,et al.  Non‐motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson′s disease patients , 2016, Acta neurologica Scandinavica.

[3]  Jean-François Gagnon,et al.  New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.

[4]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[5]  P. Chan,et al.  Heterogeneity among patients with Parkinson's disease: Cluster analysis and genetic association , 2015, Journal of the Neurological Sciences.

[6]  J. Buxbaum,et al.  PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease , 2015, Neurology.

[7]  Nicholas Eriksson,et al.  NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases , 2015, Neurobiology of Aging.

[8]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[9]  Sebastian M. Armasu,et al.  Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease? , 2014, Parkinsonism & related disorders.

[10]  V. Álvarez,et al.  Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms , 2014, Neuroscience Letters.

[11]  S. Factor,et al.  Identification of a novel Parkinson’s disease locus via stratified genome-wide association study , 2014, BMC Genomics.

[12]  D. Berg,et al.  SNCA: Major genetic modifier of age at onset of Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[13]  J. Jankovic,et al.  How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale , 2013, Movement disorders : official journal of the Movement Disorder Society.

[14]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[15]  Ting Wang,et al.  Using the Wash U Epigenome Browser to Examine Genome‐Wide Sequencing Data , 2012, Current protocols in bioinformatics.

[16]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[17]  W. P. van den Wildenberg,et al.  Differential susceptibility to motor impulsivity among functional subtypes of Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  G. Stebbins,et al.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[19]  J. Nutt,et al.  Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. , 2012, British journal of clinical pharmacology.

[20]  V. Álvarez,et al.  A Search for SNCA 3′ UTR Variants Identified SNP rs356165 as a Determinant of Disease Risk and Onset Age in Parkinson’s Disease , 2012, Journal of Molecular Neuroscience.

[21]  Beate Ritz,et al.  α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease , 2012, PloS one.

[22]  M. Shevlin,et al.  Clinical heterogeneity in Parkinson’s disease revisited: a latent profile analysis , 2012, Acta neurologica Scandinavica.

[23]  S. Landau,et al.  Parkinson's disease motor subtypes and mood , 2012, Movement disorders : official journal of the Movement Disorder Society.

[24]  V. Mok,et al.  Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  T. Feng,et al.  Clinical heterogeneity in patients with early-stage Parkinson’s disease: a cluster analysis , 2011, Journal of Zhejiang University SCIENCE B.

[26]  Ryan A. Flynn,et al.  A unique chromatin signature uncovers early developmental enhancers in humans , 2011, Nature.

[27]  K. Welsh-Bohmer,et al.  The effect of SNCA 3′ region on the levels of SNCA-112 splicing variant , 2011, neurogenetics.

[28]  Geert Molenberghs,et al.  Random Effects Models for Longitudinal Data , 2010 .

[29]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[30]  D. Galasko,et al.  SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. , 2010, Archives of neurology.

[31]  S. Factor,et al.  Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  C. Tanner,et al.  Clinical features in early Parkinson disease and survival. , 2009, Archives of neurology.

[33]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[34]  M. Farrer,et al.  Genomic investigation of α‐synuclein multiplication and parkinsonism , 2008, Annals of neurology.

[35]  D. Berg,et al.  Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[37]  A M Stiggelbout,et al.  Cognitive impairment in Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[38]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[39]  D. Aarsland,et al.  Changes in motor subtype and risk for incident dementia in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[40]  I. McKeith,et al.  Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  A. Singleton,et al.  Association of α‐synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset , 2006, Movement disorders : official journal of the Movement Disorder Society.

[42]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[43]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[44]  J. Jankovic,et al.  Functional decline in Parkinson disease. , 2001, Archives of neurology.

[45]  K. Marder,et al.  Progression of parkinsonian signs in Parkinson disease. , 1999, Archives of neurology.

[46]  Y Mizuno,et al.  [Clinical subtypes of Parkinson's disease]. , 1993, No to shinkei = Brain and nerve.

[47]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[48]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[49]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[50]  W. Weiner,et al.  The clinically important difference on the unified Parkinson's disease rating scale. , 2010, Archives of neurology.

[51]  Aj Lees,et al.  Clinical-pathological study of subtypes in Parkinson's disease , 2009 .

[52]  J. Matsumoto,et al.  Benign tremulous parkinsonism. , 2006, Archives of neurology.

[53]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .